Used primarily in research settings to study its effects as a platelet-activating factor antagonist. It has been investigated for its potential therapeutic applications in managing conditions related to inflammation and thrombosis. Studies have explored its role in mitigating the adverse effects of platelet-activating factor in various inflammatory and cardiovascular disorders. However, its clinical use remains limited, and it is mainly utilized in experimental models to understand the mechanisms of platelet-activating factor in disease processes.